{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:31:53Z","timestamp":1793374313625,"version":"4.5.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ascendis Pharma","award":["Ascendis Pharma"],"award-info":[{"award-number":["Ascendis Pharma"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02760-9","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:24:01Z","timestamp":1764753841000},"page":"725-746","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Unveiling the complexities of hypoparathyroidism: a comprehensive review of clinical manifestations, diagnosis, and novel therapies"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-9547","authenticated-orcid":false,"given":"Filomena","family":"Cetani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-7340","authenticated-orcid":false,"given":"Francesco","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-0368","authenticated-orcid":false,"given":"Marco","family":"Bononi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3783-4749","authenticated-orcid":false,"given":"Mariarita","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-951X","authenticated-orcid":false,"given":"Valentina","family":"Camozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-1202","authenticated-orcid":false,"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-4926","authenticated-orcid":false,"given":"Andrea","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5674-635X","authenticated-orcid":false,"given":"Daniela","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-2070","authenticated-orcid":false,"given":"Guido","family":"Zavatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2760_CR1","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Brandi ML, Cusano NE et al (2016) Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab 101:2313\u20132324. https:\/\/doi.org\/10.1210\/jc.2015-3910","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR2","doi-asserted-by":"publisher","first-page":"17080","DOI":"10.1038\/nrdp.2017.80","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"Mannstadt M, Bilezikian JP, Thakker RV et al (2017) Correction: hypoparathyroidism. Nat Rev Dis Primers 3:17080. https:\/\/doi.org\/10.1038\/nrdp.2017.80","journal-title":"Nat Rev Dis Primers"},{"key":"2760_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4158\/EP13328.OR","volume":"20","author":"N Hadker","year":"2014","unstructured":"Hadker N, Egan J, Sanders J et al (2014) Understanding the burden of illness associated with hypoparathyroidism reported among patients in the Paradox study. Endocr Pract 20:671\u2013679. https:\/\/doi.org\/10.4158\/EP13328.OR","journal-title":"Endocr Pract"},{"key":"2760_CR4","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1210\/jc.2016-1477","volume":"101","author":"MC Astor","year":"2016","unstructured":"Astor MC, L\u00f8v\u00e5s K, Debowska A et al (2016) Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab 101:3045\u20133053. https:\/\/doi.org\/10.1210\/jc.2016-1477","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41574-024-01075-8","volume":"21","author":"S Khan","year":"2025","unstructured":"Khan S, Khan AA (2025) Hypoparathyroidism: diagnosis, management and emerging therapies. Nat Rev Endocrinol 21:360\u2013374. https:\/\/doi.org\/10.1038\/s41574-024-01075-8","journal-title":"Nat Rev Endocrinol"},{"key":"2760_CR6","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1002\/jbmr.4714","volume":"37","author":"JL Pasieka","year":"2022","unstructured":"Pasieka JL, Wentworth K, Yeo CT et al (2022) Etiology and pathophysiology of hypoparathyroidism: a narrative review. J Bone Miner Res 37:2586\u20132601. https:\/\/doi.org\/10.1002\/jbmr.4714","journal-title":"J Bone Miner Res"},{"key":"2760_CR7","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D et al (2016) Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 101:2273\u20132283. https:\/\/doi.org\/10.1210\/jc.2015-3907","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR8","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1002\/jbmr.4675","volume":"37","author":"S Bjornsdottir","year":"2022","unstructured":"Bjornsdottir S, Ing S, Mitchell DM et al (2022) Epidemiology and financial burden of adult chronic hypoparathyroidism. J Bone Miner Res 37:2602\u20132614. https:\/\/doi.org\/10.1002\/jbmr.4675","journal-title":"J Bone Miner Res"},{"key":"2760_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-024-07352-6","volume":"36","author":"Y Yang","year":"2025","unstructured":"Yang Y, Deng Y, Sun L et al (2025) Hypoparathyroidism: similarities and differences between Western and Eastern countries. Osteoporos Int 36:391\u2013402. https:\/\/doi.org\/10.1007\/s00198-024-07352-6","journal-title":"Osteoporos Int"},{"key":"2760_CR10","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H (2013) Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res 28:2570\u20132576. https:\/\/doi.org\/10.1002\/jbmr.2004","journal-title":"J Bone Miner Res"},{"key":"2760_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13023-024-03155-4","volume":"19","author":"KL Deering","year":"2024","unstructured":"Deering KL, Larsen NJ, Loustau P et al (2024) Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data. Orphanet J Rare Dis 19:164. https:\/\/doi.org\/10.1186\/s13023-024-03155-4","journal-title":"Orphanet J Rare Dis"},{"key":"2760_CR12","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT et al (2016) Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab 101:2284\u20132299. https:\/\/doi.org\/10.1210\/jc.2015-3908","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR13","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1001\/jama.2019.19641","volume":"322","author":"SV Ahn","year":"2019","unstructured":"Ahn SV, Lee J-H, Bove-Fenderson EA et al (2019) Incidence of hypoparathyroidism after thyroid cancer surgery in South Korea, 2007\u20132016. JAMA 322:2441. https:\/\/doi.org\/10.1001\/jama.2019.19641","journal-title":"JAMA"},{"key":"2760_CR14","doi-asserted-by":"publisher","first-page":"e8245","DOI":"10.1097\/MD.0000000000008245","volume":"96","author":"K-C Chen","year":"2017","unstructured":"Chen K-C, Iqbal U, Nguyen P-A et al (2017) The impact of different surgical procedures on hypoparathyroidism after thyroidectomy: a population-based study. Medicine 96:e8245. https:\/\/doi.org\/10.1097\/MD.0000000000008245","journal-title":"Medicine"},{"key":"2760_CR15","doi-asserted-by":"publisher","first-page":"ziae100","DOI":"10.1093\/jbmrpl\/ziae100","volume":"8","author":"M Hasegawa","year":"2024","unstructured":"Hasegawa M, Sakakibara Y, Takeuchi Y et al (2024) Prevalence and characteristics of postoperative and nonoperative chronic hypoparathyroidism in Japan: a nationwide retrospective analysis. JBMR Plus 8:ziae100. https:\/\/doi.org\/10.1093\/jbmrpl\/ziae100","journal-title":"JBMR Plus"},{"key":"2760_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2188\/jea.JE20220152","volume":"33","author":"R Takatani","year":"2023","unstructured":"Takatani R, Kubota T, Minagawa M et al (2023) Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: a nationwide survey. J Epidemiol 33:569\u2013573. https:\/\/doi.org\/10.2188\/jea.JE20220152","journal-title":"J Epidemiol"},{"key":"2760_CR17","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28:2277\u20132285. https:\/\/doi.org\/10.1002\/jbmr.1979","journal-title":"J Bone Miner Res"},{"key":"2760_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jbmr.3329","volume":"33","author":"T Vadiveloo","year":"2018","unstructured":"Vadiveloo T, Donnan PT, Leese GP (2018) A population-based study of the epidemiology of chronic hypoparathyroidism. J Bone Miner Res 33:478\u2013485. https:\/\/doi.org\/10.1002\/jbmr.3329","journal-title":"J Bone Miner Res"},{"key":"2760_CR19","doi-asserted-by":"publisher","first-page":"1348971","DOI":"10.3389\/fendo.2024.1348971","volume":"15","author":"JJ D\u00edez","year":"2024","unstructured":"D\u00edez JJ, Anda E, P\u00e9rez-Corral B et al (2024) Incident comorbidities in patients with chronic hypoparathyroidism after thyroidectomy: a multicenter nationwide study. Front Endocrinol 15:1348971. https:\/\/doi.org\/10.3389\/fendo.2024.1348971","journal-title":"Front Endocrinol"},{"key":"2760_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00223-016-0222-7","volume":"100","author":"C Cipriani","year":"2017","unstructured":"Cipriani C, Pepe J, Biamonte F et al (2017) The epidemiology of hypoparathyroidism in Italy: an 8-Year register-based study. Calcif Tissue Int 100:278\u2013285. https:\/\/doi.org\/10.1007\/s00223-016-0222-7","journal-title":"Calcif Tissue Int"},{"key":"2760_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00223-018-0405-5","volume":"103","author":"L Cianferotti","year":"2018","unstructured":"Cianferotti L, Parri S, Gronchi G et al (2018) Prevalence of chronic hypoparathyroidism in a mediterranean region as estimated by the analysis of anonymous healthcare database. Calcif Tissue Int 103:144\u2013150. https:\/\/doi.org\/10.1007\/s00223-018-0405-5","journal-title":"Calcif Tissue Int"},{"key":"2760_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051956","volume":"12","author":"F Privitera","year":"2023","unstructured":"Privitera F, Centonze D, La Vignera S et al (2023) Risk factors for hypoparathyroidism after thyroid surgery: a single-center study. JCM 12:1956. https:\/\/doi.org\/10.3390\/jcm12051956","journal-title":"JCM"},{"key":"2760_CR23","doi-asserted-by":"publisher","first-page":"e0232842","DOI":"10.1371\/journal.pone.0232842","volume":"15","author":"SH Kim","year":"2020","unstructured":"Kim SH, Rhee Y, Kim YM et al (2020) Prevalence and complications of nonsurgical hypoparathyroidism in Korea: a nationwide cohort study. PLoS One 15:e0232842. https:\/\/doi.org\/10.1371\/journal.pone.0232842","journal-title":"PLoS One"},{"key":"2760_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/bjs.10843","volume":"105","author":"M Almquist","year":"2018","unstructured":"Almquist M, Ivarsson K, Nordenstr\u00f6m E, Bergenfelz A (2018) Mortality in patients with permanent hypoparathyroidism after total thyroidectomy. Br J Surg 105:1313\u20131318. https:\/\/doi.org\/10.1002\/bjs.10843","journal-title":"Br J Surg"},{"key":"2760_CR25","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/jbmr.4716","volume":"37","author":"AA Khan","year":"2022","unstructured":"Khan AA, Guyatt G, Ali DS et al (2022) Management of hypoparathyroidism. J Bone Miner Res 37:2663\u20132677. https:\/\/doi.org\/10.1002\/jbmr.4716","journal-title":"J Bone Miner Res"},{"key":"2760_CR26","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/jbmr.4667","volume":"37","author":"M Mannstadt","year":"2022","unstructured":"Mannstadt M, Cianferotti L, Gafni RI et al (2022) Hypoparathyroidism: genetics and diagnosis. J Bone Miner Res 37:2615\u20132629. https:\/\/doi.org\/10.1002\/jbmr.4667","journal-title":"J Bone Miner Res"},{"key":"2760_CR27","doi-asserted-by":"publisher","unstructured":"VenouTM, Barmpageorgopoulou F, Peppa M, Vlachaki E (2024) Endocrinopathies in beta thalassemia: a narrative review. Hormones 23(2):205\u2013216. https:\/\/doi.org\/10.1007\/s42000-023-00515-w","DOI":"10.1007\/s42000-023-00515-w"},{"key":"2760_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/B978-0-444-63625-6.00013-6","volume":"142","author":"K Dzie\u017cyc","year":"2017","unstructured":"Dzie\u017cyc K, Litwin T, Cz\u0142onkowska A (2017) Other organ involvement and clinical aspects of Wilson disease. Handb Clin Neurol 142:157\u2013169. https:\/\/doi.org\/10.1016\/B978-0-444-63625-6.00013-6","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"2760_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101046","volume":"7","author":"A Albert","year":"2025","unstructured":"Albert A, Hinkel UP, Bohlender T et al (2025) Paradoxical inadequate parathyroid hormone secretion secondary to severe hypomagnesemia: a review of the literature. Kidney Med 7(8):101046. https:\/\/doi.org\/10.1016\/j.xkme.2025.101046","journal-title":"Kidney Med"},{"key":"2760_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jc.2018-01151","volume":"104","author":"P Piranavan","year":"2019","unstructured":"Piranavan P, Li Y, Brown E et al (2019) Immune checkpoint inhibitor-induced hypoparathyroidism associated with calcium-sensing receptor-activating autoantibodies. J Clin Endocrinol Metab 104:550\u2013556. https:\/\/doi.org\/10.1210\/jc.2018-01151","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1210\/clinem\/dgaa092","volume":"105","author":"I Lupi","year":"2020","unstructured":"Lupi I, Brancatella A, Cetani F et al (2020) Activating antibodies to the calcium-sensing receptor in immunotherapy-induced hypoparathyroidism. J Clin Endocrinol Metab 105:1581\u20131588. https:\/\/doi.org\/10.1210\/clinem\/dgaa092","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s40618-024-02465-5","volume":"48","author":"Y Shen","year":"2024","unstructured":"Shen Y, Yang W, He Q et al (2024) Clinical and genetic characteristics of hypoparathyroidism in children: a multicenter experience in China. J Endocrinol Invest 48:393\u2013400. https:\/\/doi.org\/10.1007\/s40618-024-02465-5","journal-title":"J Endocrinol Invest"},{"key":"2760_CR33","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s12020-024-04110-w","volume":"87","author":"Z Kocabey S\u00fct\u00e7\u00fc","year":"2024","unstructured":"Kocabey S\u00fct\u00e7\u00fc Z, Ayta\u00e7 Kaplan EH, \u00d6nal H (2024) Pediatric hypoparathyroidism: etiological and clinical evaluation in a tertiary center. Endocrine 87:1235\u20131245. https:\/\/doi.org\/10.1007\/s12020-024-04110-w","journal-title":"Endocrine"},{"key":"2760_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/jdb10020018","volume":"10","author":"N Funato","year":"2022","unstructured":"Funato N (2022) Craniofacial phenotypes and genetics of digeorge syndrome. JDB 10:18. https:\/\/doi.org\/10.3390\/jdb10020018","journal-title":"JDB"},{"key":"2760_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1530\/EJE-21-0730","volume":"187","author":"T Cranston","year":"2022","unstructured":"Cranston T, Boon H, Olesen MK et al (2022) Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism. Eur J Endocrinol 187:111\u2013122. https:\/\/doi.org\/10.1530\/EJE-21-0730","journal-title":"Eur J Endocrinol"},{"key":"2760_CR36","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1210\/jc.2009-0717","volume":"94","author":"KU Gaynor","year":"2009","unstructured":"Gaynor KU, Grigorieva IV, Nesbit MA et al (2009) A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab 94:3897\u20133904. https:\/\/doi.org\/10.1210\/jc.2009-0717","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR37","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1210\/jc.2017-00250","volume":"102","author":"L Cinque","year":"2017","unstructured":"Cinque L, Sparaneo A, Penta L et al (2017) Autosomal dominant PTH gene signal sequence mutation in a family with familial isolated hypoparathyroidism. J Clin Endocrinol Metab 102:3961\u20133969. https:\/\/doi.org\/10.1210\/jc.2017-00250","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR38","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/jbmr.4659","volume":"37","author":"KL Roszko","year":"2022","unstructured":"Roszko KL, Stapleton Smith LM, Sridhar AV et al (2022) Autosomal dominant hypocalcemia type 1: a systematic review. J Bone Miner Res 37:1926\u20131935. https:\/\/doi.org\/10.1002\/jbmr.4659","journal-title":"J Bone Miner Res"},{"key":"2760_CR39","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/jbmr.4803","volume":"38","author":"SA Howles","year":"2023","unstructured":"Howles SA, Gorvin CM, Cranston T et al (2023) GNA11 variants identified in patients with hypercalcemia or hypocalcemia. J Bone Miner Res 38:907\u2013917. https:\/\/doi.org\/10.1002\/jbmr.4803","journal-title":"J Bone Miner Res"},{"key":"2760_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4274\/jcrpe.galenos.2021.2020.0315","volume":"15","author":"E Eren","year":"2023","unstructured":"Eren E, Tezcan \u00dcnl\u00fc H, Ceylaner S, Tar\u0131m \u00d6 (2023) Compound heterozygous variants in FAM111A cause autosomal recessive Kenny-Caffey syndrome type 2. Jcrpe 15:97\u2013102. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2021.2020.0315","journal-title":"Jcrpe"},{"key":"2760_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2433","volume":"12","author":"X Chen","year":"2024","unstructured":"Chen X, Zou C (2024) Further delineation of phenotype and genotype of Kenny\u2013Caffey syndrome type 2 (phenotype and genotype of KCS type 2). Mol Genet Genomic Med 12:e2433. https:\/\/doi.org\/10.1002\/mgg3.2433","journal-title":"Mol Genet Genomic Med"},{"key":"2760_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000848","author":"L Romo","year":"2023","unstructured":"Romo L, Gold NB, Walker MA (2023) Endocrine features of primary mitochondrial diseases. Curr Opin Endocrinol Diabetes Obes. https:\/\/doi.org\/10.1097\/MED.0000000000000848","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2760_CR43","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ecl.2018.07.007","volume":"47","author":"RJ Gordon","year":"2018","unstructured":"Gordon RJ, Levine MA (2018) Genetic disorders of parathyroid development and function. Endocrinol Metab Clin North Am 47:809\u2013823. https:\/\/doi.org\/10.1016\/j.ecl.2018.07.007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2760_CR44","doi-asserted-by":"publisher","first-page":"1415639","DOI":"10.3389\/fendo.2024.1415639","volume":"15","author":"N Mukhtar","year":"2024","unstructured":"Mukhtar N, Alghamdi B, Alswailem M et al (2024) Case report: Familial hypoparathyroidism with elevated parathyroid hormone due to an inactivating PTH mutation. Front Endocrinol 15:1415639. https:\/\/doi.org\/10.3389\/fendo.2024.1415639","journal-title":"Front Endocrinol"},{"issue":"4","key":"2760_CR45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s40618-024-02496-y","volume":"48","author":"T De Coster","year":"2025","unstructured":"De Coster T, David K, Breckpot J, Decallonne B (2025) Management of autosomal dominant hypocalcemia type 1: literature review and clinical practice recommendations. J Endocrinol Invest 48(4):831\u2013844. https:\/\/doi.org\/10.1007\/s40618-024-02496-y","journal-title":"J Endocrinol Invest"},{"issue":"9334","key":"2760_CR46","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0140-6736(02)09842-2","volume":"360","author":"S Watanabe","year":"2002","unstructured":"Watanabe S, Fukumoto S, Chang H et al (2002) Association between activating mutations of calcium-sensing receptor and Bartter\u2019s syndrome. Lancet 360(9334):692\u2013694. https:\/\/doi.org\/10.1016\/S0140-6736(02)09842-2","journal-title":"Lancet"},{"issue":"3","key":"2760_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EJE-16-0109","volume":"175","author":"S Tenhola","year":"2016","unstructured":"Tenhola S, Voutilainen R, Reyes M, Toiviainen-Salo S, J\u00fcppner H, M\u00e4kitie O (2016) Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation. Eur J Endocrinol 175(3):211\u2013218. https:\/\/doi.org\/10.1530\/EJE-16-0109","journal-title":"Eur J Endocrinol"},{"key":"2760_CR48","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1172\/JCI24156","volume":"115","author":"MR Bowl","year":"2005","unstructured":"Bowl MR, Nesbit MA, Harding B et al (2005) An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism. J Clin Invest 115:2822\u20132831. https:\/\/doi.org\/10.1172\/JCI24156","journal-title":"J Clin Invest"},{"key":"2760_CR49","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1097\/JS9.0000000000001475","volume":"110","author":"K Ning","year":"2024","unstructured":"Ning K, Yu Y, Zheng X et al (2024) Risk factors of transient and permanent hypoparathyroidism after thyroidectomy: a systematic review and meta-analysis. Int J Surg 110:5047\u20135062. https:\/\/doi.org\/10.1097\/JS9.0000000000001475","journal-title":"Int J Surg"},{"key":"2760_CR50","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/jbmr.4691","volume":"37","author":"AA Khan","year":"2022","unstructured":"Khan AA, Bilezikian JP, Brandi ML et al (2022) Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop. J Bone Miner Res 37:2568\u20132585. https:\/\/doi.org\/10.1002\/jbmr.4691","journal-title":"J Bone Miner Res"},{"key":"2760_CR51","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1530\/EJE-20-1367","volume":"184","author":"R Mihai","year":"2021","unstructured":"Mihai R, Thakker RV (2021) Management of endocrine disease: postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantation. Eur J Endocrinol 184:R165\u2013R175. https:\/\/doi.org\/10.1530\/EJE-20-1367","journal-title":"Eur J Endocrinol"},{"key":"2760_CR52","doi-asserted-by":"publisher","first-page":"156335","DOI":"10.1016\/j.metabol.2025.156335","volume":"171","author":"AA Khan","year":"2025","unstructured":"Khan AA, Ali DS, Bilezikian JP et al (2025) Best practice recommendations for the diagnosis and management of hypoparathyroidism. Metabolism 171:156335. https:\/\/doi.org\/10.1016\/j.metabol.2025.156335","journal-title":"Metabolism"},{"issue":"4","key":"2760_CR53","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1210\/clinem\/dgab039","volume":"106","author":"KD Vaitsi","year":"2021","unstructured":"Vaitsi KD, Anagnostis P, Veneti S, Papavramidis TS, Goulis DG (2021) Preoperative vitamin D deficiency is a risk factor for postthyroidectomy hypoparathyroidism: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab 106(4):1209\u20131224. https:\/\/doi.org\/10.1210\/clinem\/dgab039","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR54","doi-asserted-by":"publisher","first-page":"e0221173","DOI":"10.1371\/journal.pone.0221173","volume":"14","author":"B Wang","year":"2019","unstructured":"Wang B, Zhu C-R, Liu H et al (2019) The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: a meta-analysis. PLoS One 14:e0221173. https:\/\/doi.org\/10.1371\/journal.pone.0221173","journal-title":"PLoS One"},{"key":"2760_CR55","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/08941939.2018.1441344","volume":"32","author":"O Iorio","year":"2019","unstructured":"Iorio O, Petrozza V, De Gori A et al (2019) Parathyroid autotransplantation during thyroid surgery. Where we are? A systematic review on indications and results. J Invest Surg 32:594\u2013601. https:\/\/doi.org\/10.1080\/08941939.2018.1441344","journal-title":"J Invest Surg"},{"key":"2760_CR56","doi-asserted-by":"publisher","unstructured":"Lelli G, Micalizzi A, Gurrado A et al (2024) 5-year follow-up of reimplanted parathyroid glands in forearm subcutaneous tissue during thyroidectomy. A confirmation of graft vitality in a large series of patients. The American SurgeonTM 90:1514\u20131520. https:\/\/doi.org\/10.1177\/00031348241244631","DOI":"10.1177\/00031348241244631"},{"key":"2760_CR57","doi-asserted-by":"publisher","first-page":"604","DOI":"10.20945\/2359-3997000000549","volume":"66","author":"BL Clarke","year":"2022","unstructured":"Clarke BL (2022) Hypoparathyroidism: update of guidelines from the 2022 international task force. Arch Endocrinol Metab 66:604\u2013610. https:\/\/doi.org\/10.20945\/2359-3997000000549","journal-title":"Arch Endocrinol Metab"},{"key":"2760_CR58","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1308\/rcsann.2021.0318","volume":"104","author":"M Tarallo","year":"2022","unstructured":"Tarallo M, Crocetti D, Gurrado A et al (2022) Achieving the learning curve in total thyroidectomy: a prospective evaluation on resident\u2019s training by CUSUM and KPSS analysis. Annals 104:414\u2013420. https:\/\/doi.org\/10.1308\/rcsann.2021.0318","journal-title":"Annals"},{"key":"2760_CR59","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/JS9.0000000000000991","volume":"110","author":"D Lu","year":"2024","unstructured":"Lu D, Pan B, Tang E et al (2024) Intraoperative strategies in identification and functional protection of parathyroid glands for patients with thyroidectomy: a systematic review and network meta-analysis. Int J Surg 110:1723\u20131734. https:\/\/doi.org\/10.1097\/JS9.0000000000000991","journal-title":"Int J Surg"},{"key":"2760_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00268-022-06683-x","volume":"47","author":"P Moreno-Llorente","year":"2023","unstructured":"Moreno-Llorente P, Garc\u00eda\u2010Barrasa A, Pascua\u2010Sol\u00e9 M et al (2023) Usefulness of ICG angiography\u2010guided thyroidectomy for preserving parathyroid function. World J Surg 47:421\u2013428. https:\/\/doi.org\/10.1007\/s00268-022-06683-x","journal-title":"World j surg"},{"key":"2760_CR61","doi-asserted-by":"publisher","first-page":"1086367","DOI":"10.3389\/fendo.2023.1086367","volume":"14","author":"J Huang","year":"2023","unstructured":"Huang J, He Y, Wang Y et al (2023) Prevention of hypoparathyroidism: a step-by-step near-infrared autofluorescence parathyroid identification method. Front Endocrinol 14:1086367. https:\/\/doi.org\/10.3389\/fendo.2023.1086367","journal-title":"Front Endocrinol"},{"key":"2760_CR62","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12020-022-03222-5","volume":"79","author":"D Barbieri","year":"2022","unstructured":"Barbieri D, Indelicato P, Vinciguerra A et al (2022) The impact of near-infrared autofluorescence on postoperative hypoparathyroidism during total thyroidectomy: a case\u2013control study. Endocrine 79:392\u2013399. https:\/\/doi.org\/10.1007\/s12020-022-03222-5","journal-title":"Endocrine"},{"key":"2760_CR63","doi-asserted-by":"publisher","first-page":"1131947","DOI":"10.3389\/fendo.2023.1131947","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Bo H, Xu Y et al (2023) Application of carbon nanoparticles combined with refined extracapsular anatomy in endoscopic thyroidectomy. Front Endocrinol 14:1131947. https:\/\/doi.org\/10.3389\/fendo.2023.1131947","journal-title":"Front Endocrinol"},{"key":"2760_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0002-9610(58)90868-7","volume":"96","author":"E Hoffman","year":"1958","unstructured":"Hoffman E (1958) The Chvostek sign: a clinical study. Am J Surg 96:33\u201337. https:\/\/doi.org\/10.1016\/0002-9610(58)90868-7","journal-title":"Am J Surg"},{"key":"2760_CR65","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","volume":"105","author":"JP Bilezikian","year":"2020","unstructured":"Bilezikian JP (2020) Hypoparathyroidism. J Clin Endocrinol Metabolism 105:1722\u20131736. https:\/\/doi.org\/10.1210\/clinem\/dgaa113","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2760_CR66","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","volume":"77","author":"R Goswami","year":"2012","unstructured":"Goswami R, Sharma R, Sreenivas V et al (2012) Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clinical Endocrinology 77:200\u2013206. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04353.x","journal-title":"Clinical Endocrinology"},{"key":"2760_CR67","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1210\/clinem\/dgab162","volume":"106","author":"G Zavatta","year":"2021","unstructured":"Zavatta G, Tebben PJ, McCollough CH et al (2021) Basal ganglia calcification is associated with local and systemic metabolic mechanisms in adult hypoparathyroidism. J Clin Endocrinol Metab 106:1900\u20131917. https:\/\/doi.org\/10.1210\/clinem\/dgab162","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR68","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1515\/cclm-2019-0568","volume":"58","author":"J-D Pekar","year":"2020","unstructured":"Pekar J-D, Grzych G, Durand G et al (2020) Calcium state estimation by total calcium: the evidence to end the never-ending story. Clin Chem Lab Med (CCLM) 58:222\u2013231. https:\/\/doi.org\/10.1515\/cclm-2019-0568","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"2760_CR69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cen.14326","volume":"94","author":"M Schini","year":"2021","unstructured":"Schini M, Hannan FM, Walsh JS, Eastell R (2021) Reference interval for albumin-adjusted calcium based on a large UK population. Clin Endocrinol 94:34\u201339. https:\/\/doi.org\/10.1111\/cen.14326","journal-title":"Clin Endocrinol"},{"key":"2760_CR70","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1210\/er.2018-00220","volume":"40","author":"MA Smit","year":"2019","unstructured":"Smit MA, Van Kinschot CMJ, Van Der Linden J et al (2019) Clinical guidelines and PTH measurement: does assay generation matter? Endocr Rev 40:1468\u20131480. https:\/\/doi.org\/10.1210\/er.2018-00220","journal-title":"Endocr Rev"},{"key":"2760_CR71","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.surg.2004.06.053","volume":"136","author":"CP Lombardi","year":"2004","unstructured":"Lombardi CP, Raffaelli M, Princi P et al (2004) Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement. Surgery 136:1236\u20131241. https:\/\/doi.org\/10.1016\/j.surg.2004.06.053","journal-title":"Surgery"},{"key":"2760_CR72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1445-2197.2007.04018.x","volume":"77","author":"AES Guidelines 06\/01 Group","year":"2007","unstructured":"AES Guidelines 06\/01 Group (2007) Australian endocrine surgeons guidelines AES06\/01. Postoperative parathyroid hormone measurement and early discharge after total thyroidectomy: analysis of Australian data and management recommendations. ANZ J Surg 77:199\u2013202. https:\/\/doi.org\/10.1111\/j.1445-2197.2007.04018.x","journal-title":"ANZ J Surg"},{"key":"2760_CR73","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1089\/thy.2017.0309","volume":"28","author":"LA Orloff","year":"2018","unstructured":"Orloff LA, Wiseman SM, Bernet VJ et al (2018) American thyroid association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid 28:830\u2013841. https:\/\/doi.org\/10.1089\/thy.2017.0309","journal-title":"Thyroid"},{"key":"2760_CR74","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/hed.21175","volume":"32","author":"HM Mehanna","year":"2010","unstructured":"Mehanna HM, Jain A, Randeva H et al (2010) Postoperative hypocalcemia\u2014the difference a definition makes. Head Neck 32:279\u2013283. https:\/\/doi.org\/10.1002\/hed.21175","journal-title":"Head Neck"},{"key":"2760_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bjs.9384","volume":"101","author":"O Edafe","year":"2014","unstructured":"Edafe O, Antakia R, Laskar N et al (2014) Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg 101:307\u2013320. https:\/\/doi.org\/10.1002\/bjs.9384","journal-title":"Br J Surg"},{"key":"2760_CR76","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"Bollerslev J, Rejnmark L, Zahn A et al (2022) European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders (PARAT 2021). Eur J Endocrinol 186:R33\u2013R63. https:\/\/doi.org\/10.1530\/EJE-21-1044","journal-title":"Eur J Endocrinol"},{"key":"2760_CR77","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.21037\/gs.2017.10.04","volume":"6","author":"A Sitges-Serra","year":"2017","unstructured":"Sitges-Serra A, G\u00f3mez J, Barczynski M et al (2017) A nomogram to predict the likelihood of permanent hypoparathyroidism after total thyroidectomy based on delayed serum calcium and iPTH measurements. Gland Surg 6:S11\u2013S19. https:\/\/doi.org\/10.21037\/gs.2017.10.04","journal-title":"Gland Surg"},{"key":"2760_CR78","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"Shoback DM, Bilezikian JP, Costa AG et al (2016) Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab 101:2300\u20132312. https:\/\/doi.org\/10.1210\/jc.2015-3909","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR79","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1007\/s00268-019-04987-z","volume":"43","author":"G Ponce De Le\u00f3n-Ballesteros","year":"2019","unstructured":"Ponce De Le\u00f3n-Ballesteros G, Vel\u00e1zquez\u2010Fern\u00e1ndez D, Hern\u00e1ndez\u2010Calder\u00f3n FJ et al (2019) Hypoparathyroidism after total thyroidectomy: importance of the intraoperative management of the parathyroid glands. World J Surg 43:1728\u20131735. https:\/\/doi.org\/10.1007\/s00268-019-04987-z","journal-title":"World J Surg"},{"key":"2760_CR80","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT et al (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26:2317\u20132337. https:\/\/doi.org\/10.1002\/jbmr.483","journal-title":"J Bone Miner Res"},{"key":"2760_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cca.2021.03.002","volume":"517","author":"K Makris","year":"2021","unstructured":"Makris K, Bhattoa HP, Cavalier E et al (2021) Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein \u2013 a position paper from the IFCC committee on bone metabolism. Clin Chim Acta 517:171\u2013197. https:\/\/doi.org\/10.1016\/j.cca.2021.03.002","journal-title":"Clin Chim Acta"},{"key":"2760_CR82","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1074\/jbc.M007727200","volume":"276","author":"U Quitterer","year":"2001","unstructured":"Quitterer U, Hoffmann M, Freichel M, Lohse MJ (2001) Paradoxical block of parathormone secretion is mediated by increased activity of G\u03b1 subunits. J Biol Chem 276:6763\u20136769. https:\/\/doi.org\/10.1074\/jbc.M007727200","journal-title":"J Biol Chem"},{"key":"2760_CR83","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2019","unstructured":"Khan AA, Koch CA, Van Uum S et al (2019) Standards of care for hypoparathyroidism in adults: a Canadian and International consensus. Eur J Endocrinol 180:P1\u2013P22. https:\/\/doi.org\/10.1530\/EJE-18-0609","journal-title":"Eur J Endocrinol"},{"key":"2760_CR84","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/jbmr.452","volume":"26","author":"MR Rubin","year":"2011","unstructured":"Rubin MR, Dempster DW, Sliney J Jr. et al (2011) PTH(1\u201384) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res 26:2727\u20132736. https:\/\/doi.org\/10.1002\/jbmr.452","journal-title":"J Bone Miner Res"},{"key":"2760_CR85","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11154-020-09614-0","volume":"22","author":"BC Silva","year":"2021","unstructured":"Silva BC, Bilezikian JP (2021) Skeletal abnormalities in hypoparathyroidism and in primary hyperparathyroidism. Rev Endocr Metab Disord 22:789\u2013802. https:\/\/doi.org\/10.1007\/s11154-020-09614-0","journal-title":"Rev Endocr Metab Disord"},{"key":"2760_CR86","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2265.2006.02479.x","volume":"64","author":"BA Laway","year":"2006","unstructured":"Laway BA, Goswami R, Singh N et al (2006) Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol 64:405\u2013409. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02479.x","journal-title":"Clin Endocrinol"},{"key":"2760_CR87","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Dempster DW, Zhou H et al (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23:2018\u20132024. https:\/\/doi.org\/10.1359\/jbmr.080803","journal-title":"J Bone Miner Res"},{"key":"2760_CR88","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00198-016-3750-0","volume":"28","author":"BC Silva","year":"2017","unstructured":"Silva BC, Rubin MR, Cusano NE, Bilezikian JP (2017) Bone imaging in hypoparathyroidism. Osteoporos Int 28:463\u2013471. https:\/\/doi.org\/10.1007\/s00198-016-3750-0","journal-title":"Osteoporos Int"},{"key":"2760_CR89","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00198-021-05966-8","volume":"32","author":"R Pal","year":"2021","unstructured":"Pal R, Bhadada SK, Mukherjee S et al (2021) Fracture risk in hypoparathyroidism: a systematic review and meta-analysis. Osteoporos Int 32:2145\u20132153. https:\/\/doi.org\/10.1007\/s00198-021-05966-8","journal-title":"Osteoporos Int"},{"key":"2760_CR90","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s40618-022-01818-2","volume":"45","author":"S Saha","year":"2022","unstructured":"Saha S, Mannar V, Kandasamy D et al (2022) Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism. J Endocrinol Invest 45:1777\u20131786. https:\/\/doi.org\/10.1007\/s40618-022-01818-2","journal-title":"J Endocrinol Invest"},{"key":"2760_CR91","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jbmr.2609","volume":"31","author":"NE Cusano","year":"2016","unstructured":"Cusano NE, Nishiyama KK, Zhang C et al (2016) Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism. J Bone Miner Res 31:308\u2013316. https:\/\/doi.org\/10.1002\/jbmr.2609","journal-title":"J Bone Miner Res"},{"key":"2760_CR92","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","volume":"29","author":"L Underbjerg","year":"2014","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism\u2014risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 29:2504\u20132510. https:\/\/doi.org\/10.1002\/jbmr.2273","journal-title":"J Bone Miner Res"},{"key":"2760_CR93","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The epidemiology of nonsurgical hypoparathyroidism in denmark: a nationwide case finding study. J Bone Miner Res 30:1738\u20131744. https:\/\/doi.org\/10.1002\/jbmr.2501","journal-title":"J Bone Miner Res"},{"key":"2760_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf061","author":"S Bjornsdottir","year":"2025","unstructured":"Bjornsdottir S, Kamal W, Mannstadt M et al (2025) Increased risk of vertebral fractures and reduced risk of femur fractures in patients with chronic hypoparathyroidism: a nationwide cohort study in Sweden. J Bone Miner Res. https:\/\/doi.org\/10.1093\/jbmr\/zjaf061","journal-title":"J Bone Miner Res"},{"key":"2760_CR95","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s11914-023-00790-x","volume":"21","author":"L Rejnmark","year":"2023","unstructured":"Rejnmark L, Underbjerg L (2023) Fracture risk in patients with hypoparathyroidism. Curr Osteoporos Rep 21:632\u2013636. https:\/\/doi.org\/10.1007\/s11914-023-00790-x","journal-title":"Curr Osteoporos Rep"},{"key":"2760_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-13-1","volume":"13","author":"ML Mendon\u00e7a","year":"2013","unstructured":"Mendon\u00e7a ML, Pereira FA, Nogueira-Barbosa MH et al (2013) Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr Disord 13:1. https:\/\/doi.org\/10.1186\/1472-6823-13-1","journal-title":"BMC Endocr Disord"},{"key":"2760_CR97","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3292","author":"H Chawla","year":"2016","unstructured":"Chawla H, Saha S, Kandaswamy D et al (2016) Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long term follow-up. J Clin Endocrinol &. Metabolism jc.2016\u20133292 https:\/\/doi.org\/10.1210\/jc.2016-3292","journal-title":"J Clin Endocrinol &"},{"issue":"1","key":"2760_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-024-01819-790","volume":"25","author":"X Li","year":"2025","unstructured":"Li X, Zhang T, Zhang H, Liu S, Tian L (2025) Effects of levothyroxine therapy on bone and mineral metabolism in hypothyroidism: a systematic review and meta-analysis. BMC Endocr Disord 25(1):11. https:\/\/doi.org\/10.1186\/s12902-024-01819-790","journal-title":"BMC Endocr Disord"},{"key":"2760_CR99","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11154-020-09613-1","volume":"22","author":"EO Gosmanova","year":"2021","unstructured":"Gosmanova EO, Houillier P, Rejnmark L et al (2021) Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review: renal disease in chronic hypoparathyroidism. Rev Endocr Metab Disord 22:297\u2013316. https:\/\/doi.org\/10.1007\/s11154-020-09613-1","journal-title":"Rev Endocr Metab Disord"},{"key":"2760_CR100","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz319","volume":"105","author":"S Saha","year":"2020","unstructured":"Saha S, Kandasamy D, Sharma R et al (2020) Nephrocalcinosis, renal dysfunction, and calculi in patients with primary hypoparathyroidism on long-term conventional therapy. J Clin Endocrinol Metab 105:e1215\u2013e1224. https:\/\/doi.org\/10.1210\/clinem\/dgz319","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR101","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40618-018-0857-5","volume":"41","author":"A Meola","year":"2018","unstructured":"Meola A, Vignali E, Matrone A et al (2018) Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest 41:1221\u20131226. https:\/\/doi.org\/10.1007\/s40618-018-0857-5","journal-title":"J Endocrinol Invest"},{"key":"2760_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13895","volume":"90","author":"T Vadiveloo","year":"2019","unstructured":"Vadiveloo T, Donnan PT, Leese CJ et al (2019) Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin Endocrinol 90:285\u2013292. https:\/\/doi.org\/10.1111\/cen.13895","journal-title":"Clin Endocrinol"},{"key":"2760_CR103","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jbmr.3368","volume":"33","author":"L Underbjerg","year":"2018","unstructured":"Underbjerg L, Sikjaer T, Rejnmark L (2018) Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: a case-control study. J Bone Miner Res 33:822\u2013831. https:\/\/doi.org\/10.1002\/jbmr.3368","journal-title":"J Bone Miner Res"},{"key":"2760_CR104","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s12325-021-01658-1","volume":"38","author":"EO Gosmanova","year":"2021","unstructured":"Gosmanova EO, Chen K, Rejnmark L et al (2021) Risk of chronic kidney disease and estimated glomerular filtration rate decline in patients with chronic hypoparathyroidism: a retrospective cohort study. Adv Ther 38:1876\u20131888. https:\/\/doi.org\/10.1007\/s12325-021-01658-1","journal-title":"Adv Ther"},{"key":"2760_CR105","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40618-021-01686-2","volume":"45","author":"L Mazoni","year":"2022","unstructured":"Mazoni L, Matrone A, Apicella M et al (2022) Renal complications and quality of life in postsurgical hypoparathyroidism: a case\u2013control study. J Endocrinol Invest 45:573\u2013582. https:\/\/doi.org\/10.1007\/s40618-021-01686-2","journal-title":"J Endocrinol Invest"},{"key":"2760_CR106","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.surg.2024.05.005","volume":"176","author":"Y Luk","year":"2024","unstructured":"Luk Y, Fung MMH, Lui DTW et al (2024) Long-term kidney outcomes in patients with permanent hypoparathyroidism after total thyroidectomy for benign disease: a population-based study. Surgery 176:700\u2013707. https:\/\/doi.org\/10.1016\/j.surg.2024.05.005","journal-title":"Surgery"},{"key":"2760_CR107","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1530\/EJE-14-0075","volume":"170","author":"S Modi","year":"2014","unstructured":"Modi S, Tripathi M, Saha S, Goswami R (2014) Seizures in patients with idiopathic hypoparathyroidism: effect of antiepileptic drug withdrawal on recurrence of seizures and serum calcium control. Eur J Endocrinol 170:777\u2013783. https:\/\/doi.org\/10.1530\/EJE-14-0075","journal-title":"Eur J Endocrinol"},{"key":"2760_CR108","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11136-020-02607-1","volume":"30","author":"M Brod","year":"2021","unstructured":"Brod M, Waldman LT, Smith A, Karpf D (2021) Living with hypoparathyroidism: development of the hypoparathyroidism patient experience Scale-Impact (HPES-Impact). Qual Life Res 30:277\u2013291. https:\/\/doi.org\/10.1007\/s11136-020-02607-1","journal-title":"Qual Life Res"},{"key":"2760_CR109","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jbmr\/zjae063","volume":"39","author":"T Sikjaer","year":"2024","unstructured":"Sikjaer T, Eskildsen SF, Underbjerg L et al (2024) Hypoparathyroidism: changes in brain structure, cognitive impairment, and reduced quality of life. J Bone Miner Res 39:855\u2013866. https:\/\/doi.org\/10.1093\/jbmr\/zjae063","journal-title":"J Bone Miner Res"},{"key":"2760_CR110","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ecl.2018.07.001","volume":"47","author":"NE Cusano","year":"2018","unstructured":"Cusano NE, Bilezikian JP (2018) Signs and symptoms of hypoparathyroidism. Endocrinol Metab Clin North Am 47:759\u2013770. https:\/\/doi.org\/10.1016\/j.ecl.2018.07.001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2760_CR111","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12020-021-02629-w","volume":"72","author":"AA Khan","year":"2021","unstructured":"Khan AA, AbuAlrob H, Punthakee Z et al (2021) Canadian National hypoparathyroidism registry: an overview of hypoparathyroidism in Canada. Endocrine 72:553\u2013561. https:\/\/doi.org\/10.1007\/s12020-021-02629-w","journal-title":"Endocrine"},{"key":"2760_CR112","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1212\/WNL.32.7.779","volume":"32","author":"C Sachs","year":"1982","unstructured":"Sachs C, Sj\u00f4berg H-E, Ericson K (1982) Basal ganglia calcifications on CT: relation to hypoparathyroidism. Neurology 32:779\u2013779. https:\/\/doi.org\/10.1212\/WNL.32.7.779","journal-title":"Neurology"},{"key":"2760_CR113","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1210\/jc.2013-3863","volume":"99","author":"R Goswami","year":"2014","unstructured":"Goswami R, Millo T, Mishra S et al (2014) Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for basal ganglia calcification in hypoparathyroidism. J Clin Endocrinol Metab 99:1741\u20131748. https:\/\/doi.org\/10.1210\/jc.2013-3863","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2760_CR114","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40618-020-01355-w","volume":"44","author":"G Zavatta","year":"2021","unstructured":"Zavatta G, Clarke BL (2021) Basal ganglia calcification in hypoparathyroidism and pseudohypoparathyroidism: local and systemic metabolic mechanisms. J Endocrinol Invest 44(2):245\u2013253. https:\/\/doi.org\/10.1007\/s40618-020-01355-w","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2760_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13050714","volume":"13","author":"C Dettori","year":"2023","unstructured":"Dettori C, Ronca F, Scalese M, Saponaro F (2023) Parathyroid hormone (PTH)-related peptides family: an intriguing role in the central nervous system. J Pers Med 13(5):714. https:\/\/doi.org\/10.3390\/jpm13050714","journal-title":"J Pers Med"},{"issue":"12","key":"2760_CR116","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf257","volume":"110","author":"S Bjornsdottir","year":"2025","unstructured":"Bjornsdottir S, Mannstadt M, Clarke B et al (2025) Increased risk of cardiovascular diseases in patients with chronic hypoparathyroidism in Sweden. J Clin Endocrinol Metab dgaf257. https:\/\/doi.org\/10.1210\/clinem\/dgaf257","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR117","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04235-6","author":"R Santori","year":"2025","unstructured":"Santori R, Menafra V, Sgreccia A et al (2025) Arrhythmic burden of long-term postsurgical hypoparathyroidism assessed with 24-hour Holter ECG. Endocrine. https:\/\/doi.org\/10.1007\/s12020-025-04235-6","journal-title":"Endocrine"},{"key":"2760_CR118","doi-asserted-by":"publisher","first-page":"e1062","DOI":"10.1210\/clinem\/dgae346","volume":"110","author":"P Namjoshi","year":"2025","unstructured":"Namjoshi P, Saha S, Sharma V et al (2025) Significance of QTc interval in chronic hypoparathyroidism and its correlates. J Clin Endocrinol Metab 110:e1062\u2013e1067. https:\/\/doi.org\/10.1210\/clinem\/dgae346","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2760_CR119","doi-asserted-by":"publisher","first-page":"G7","DOI":"10.1530\/EC-16-0056","volume":"5","author":"J Turner","year":"2016","unstructured":"Turner J, Gittoes N, Selby P (2016) Society for endocrinology endocrine emergency guidance: emergency management of acute hypocalcaemia in adult patients. Endocr Connect 5(5):G7\u2013G8. https:\/\/doi.org\/10.1530\/EC-16-0056","journal-title":"Endocr Connect"},{"key":"2760_CR120","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C et al (2015) European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173:G1\u2013G20. https:\/\/doi.org\/10.1530\/EJE-15-0628","journal-title":"Eur J Endocrinol"},{"key":"2760_CR121","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jbmr.5650030303","volume":"3","author":"JA Harvey","year":"1988","unstructured":"Harvey JA, Zobitz MM, Pak CYC (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3:253\u2013258. https:\/\/doi.org\/10.1002\/jbmr.5650030303","journal-title":"J Bone Miner Res"},{"key":"2760_CR122","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11154-019-09520-0","volume":"20","author":"A Palermo","year":"2019","unstructured":"Palermo A, Naciu AM, Tabacco G et al (2019) Calcium citrate: from biochemistry and physiology to clinical applications. Rev Endocr Metab Disord 20:353\u2013364. https:\/\/doi.org\/10.1007\/s11154-019-09520-0","journal-title":"Rev Endocr Metab Disord"},{"key":"2760_CR123","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/jbmr.4564","volume":"37","author":"AM Naciu","year":"2020","unstructured":"Naciu AM, Tabacco G, Bilezikian JP et al (2020) Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial. J Bone Miner Res 37:1251\u20131259. https:\/\/doi.org\/10.1002\/jbmr.4564","journal-title":"J Bone Miner Res"},{"key":"2760_CR124","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/0115426507022003286","volume":"22","author":"DA Straub","year":"2007","unstructured":"Straub DA (2007) Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nut Clin Pract 22:286\u2013296. https:\/\/doi.org\/10.1177\/0115426507022003286","journal-title":"Nut Clin Pract"},{"key":"2760_CR125","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1210\/jcem-55-2-238","volume":"55","author":"K Okano","year":"1982","unstructured":"Okano K, Furukawa Y, Morii H, Fujita T (1982) Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism. J Clin Endocrinol Metab 55:238\u2013243. https:\/\/doi.org\/10.1210\/jcem-55-2-238","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jbmr.5650020604","volume":"2","author":"Y Seino","year":"1987","unstructured":"Seino Y, Tanaka H, Yamaoka K, Yabuuchi H (1987) Circulating 1 alpha,25-dihydroxyvitamin D levels after a single dose of 1 alpha,25-dihydroxyvitamin D3 or 1 alpha-hydroxyvitamin D3 in normal men. Bone Miner 2:479\u2013485","journal-title":"Bone Miner"},{"issue":"9","key":"2760_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092562","volume":"19","author":"M Sabol","year":"2018","unstructured":"Sabol M, Trnski D, Musani V, Ozreti\u0107 P, Levanat S (2018) Role of GLI transcription factors in pathogenesis and their potential as new therapeutic targets. Int J Mol Sci 19(9):2562. https:\/\/doi.org\/10.3390\/ijms19092562","journal-title":"Int J Mol Sci"},{"key":"2760_CR128","volume":"8","author":"SA Atkinson","year":"2011","unstructured":"Atkinson SA (2011) [The new dietary reference intakes from the Institute of Medicine for calcium and vitamin D]. Perspect Infirm 8:5","journal-title":"Perspect Infirm"},{"key":"2760_CR129","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53\u201358. https:\/\/doi.org\/10.1210\/jc.2010-2704","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR130","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-2552","volume":"93","author":"KK Winer","year":"2008","unstructured":"Winer KK, Sinaii N, Peterson D et al (2008) Effects of once versus twice-daily parathyroid hormone 1\u201334 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93:3389\u20133395. https:\/\/doi.org\/10.1210\/jc.2007-2552","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR131","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1210\/jcem.83.10.5185","volume":"83","author":"KK Winer","year":"1998","unstructured":"Winer KK, Yanovski JA, Sarani B, Cutler GB Jr. (1998) A Randomized, Cross-Over trial of Once-Daily versus Twice-Daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism. J Clin Endocrinol Metabolism 83:3480\u20133486. https:\/\/doi.org\/10.1210\/jcem.83.10.5185","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2760_CR132","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1210\/jc.2015-2347","volume":"100","author":"KK Winer","year":"2015","unstructured":"Winer KK, Zhang B, Shrader JA et al (2015) Corrigenda: synthetic human parathyroid hormone 1\u201334 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab 100:2800\u20132800. https:\/\/doi.org\/10.1210\/jc.2015-2347","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR133","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jbmr.4452","volume":"37","author":"KL Roszko","year":"2022","unstructured":"Roszko KL, Hu TY, Guthrie LC et al (2022) PTH 1\u201334 replacement therapy has minimal effect on quality of life in patients with hypoparathyroidism. J Bone Miner Res 37:68\u201377. https:\/\/doi.org\/10.1002\/jbmr.4452","journal-title":"J Bone Miner Res"},{"key":"2760_CR134","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/jc.2017-01555","volume":"103","author":"A Palermo","year":"2018","unstructured":"Palermo A, Santonati A, Tabacco G et al (2018) PTH(1\u201334) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab 103:271\u2013280. https:\/\/doi.org\/10.1210\/jc.2017-01555","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR135","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1210\/jc.2015-1855","volume":"100","author":"A Santonati","year":"2015","unstructured":"Santonati A, Palermo A, Maddaloni E et al (2015) PTH(1\u201334) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab 100:3590\u20133597. https:\/\/doi.org\/10.1210\/jc.2015-1855","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR136","unstructured":"Rubin MR, Khan AA, Schwarz P et al (2024) Palopegteriparatide Improves Skeletal Dynamics in Adults with Chronic Hypoparathyroidism: 3 Year Results of the Phase 2 PaTH Forward Trial. Oral presentation. The American Society for Bone and Mineral Research (ASBMR) Annual Meeting Toronto September 27-30th"},{"key":"2760_CR137","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","volume":"36","author":"BL Clarke","year":"2014","unstructured":"Clarke BL, Kay Berg J, Fox J et al (2014) Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1\u201384) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clin Ther 36:722\u2013736. https:\/\/doi.org\/10.1016\/j.clinthera.2014.04.001","journal-title":"Clin Ther"},{"key":"2760_CR138","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/jbmr.1964","volume":"28","author":"T Sikjaer","year":"2013","unstructured":"Sikjaer T, Amstrup AK, Rolighed L et al (2013) PTH(1\u201384) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. J Bone Miner Res 28:2232\u20132243. https:\/\/doi.org\/10.1002\/jbmr.1964","journal-title":"J Bone Miner Res"},{"key":"2760_CR139","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70206-7","volume":"1","author":"M Mannstadt","year":"2014","unstructured":"Mannstadt M, Clarke BL, Vokes T et al (2014) Correction: Efficacy and safety of Recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol 1:275\u2013283. https:\/\/doi.org\/10.1016\/S2213-8587(13)70206-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2760_CR140","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12020-016-1141-0","volume":"55","author":"BL Clarke","year":"2017","unstructured":"Clarke BL, Vokes TJ, Bilezikian JP et al (2017) Effects of parathyroid hormone rhPTH(1\u201384) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Endocrine 55:273\u2013282. https:\/\/doi.org\/10.1007\/s12020-016-1141-0","journal-title":"Endocrine"},{"key":"2760_CR141","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1210\/jc.2019-00893","volume":"104","author":"Y-KD Tay","year":"2019","unstructured":"Tay Y-KD, Tabacco G, Cusano NE et al (2019) Therapy of hypoparathyroidism with rhPTH(1\u201384): a prospective, 8-year investigation of efficacy and safety. J Clin Endocrinol Metab 104:5601\u20135610. https:\/\/doi.org\/10.1210\/jc.2019-00893","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR142","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1210\/jc.2019-01010","volume":"104","author":"M Mannstadt","year":"2019","unstructured":"Mannstadt M, Clarke BL, Bilezikian JP et al (2019) Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism. J Clin Endocrinol Metab 104:5136\u20135147. https:\/\/doi.org\/10.1210\/jc.2019-01010","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR143","doi-asserted-by":"publisher","unstructured":"Tay Y-KD, Tabacco G, Bilezikian JP (2021) Bone quality in hypoparathyroidism. Minerva Endocrinol 46. https:\/\/doi.org\/10.23736\/S2724-6507.21.03527-2","DOI":"10.23736\/S2724-6507.21.03527-2"},{"key":"2760_CR144","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/jbmr.3543","volume":"33","author":"MR Rubin","year":"2018","unstructured":"Rubin MR, Zhou H, Cusano NE et al (2018) The effects of long-term administration of rhPTH(1\u201384) in hypoparathyroidism by bone histomorphometry. J Bone Miner Res 33:1931\u20131939. https:\/\/doi.org\/10.1002\/jbmr.3543","journal-title":"J Bone Miner Res"},{"key":"2760_CR145","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jbmr.4005","volume":"35","author":"NE Cusano","year":"2020","unstructured":"Cusano NE, Rubin MR, Williams JM et al (2020) Changes in skeletal microstructure through four continuous years of rhPTH(1\u201384) therapy in hypoparathyroidism. J Bone Miner Res 35:1274\u20131281. https:\/\/doi.org\/10.1002\/jbmr.4005","journal-title":"J Bone Miner Res"},{"key":"2760_CR146","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1210\/jc.2018-02430","volume":"104","author":"G Tabacco","year":"2019","unstructured":"Tabacco G, Tay Y-KD, Cusano NE et al (2019) Quality of life in hypoparathyroidism improves with rhPTH(1\u201384) throughout 8 years of therapy. J Clin Endocrinol Metab 104:2748\u20132756. https:\/\/doi.org\/10.1210\/jc.2018-02430","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR147","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","volume":"25","author":"T Sikjaer","year":"2014","unstructured":"Sikjaer T, Rolighed L, Hess A et al (2014) Effects of PTH(1\u201384) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int 25:1717\u20131726. https:\/\/doi.org\/10.1007\/s00198-014-2677-6","journal-title":"Osteoporos Int"},{"key":"2760_CR148","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1210\/jc.2017-01471","volume":"103","author":"TJ Vokes","year":"2018","unstructured":"Vokes TJ, Mannstadt M, Levine MA et al (2018) Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism. J Clin Endocrinol Metab 103:722\u2013731. https:\/\/doi.org\/10.1210\/jc.2017-01471","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2760_CR149","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ejendo\/lvaf148","volume":"193","author":"ML Brandi","year":"2025","unstructured":"Brandi ML, Vokes T, Appelman-Dijkstra NM et al (2025) rhPTH(1\u201384) for hypoparathyroidism: a randomized study of patient-reported outcomes. Eur J Endocrinol 193(2):310\u2013319. https:\/\/doi.org\/10.1093\/ejendo\/lvaf148","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2760_CR150","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jbmr.4780","volume":"38","author":"S Agarwal","year":"2023","unstructured":"Agarwal S, McMahon DJ, Chen J et al (2023) The clinical and skeletal effects of long-term therapy of hypoparathyroidism with rhPTH(1\u201384). J Bone Miner Res 38(4):480\u2013492. https:\/\/doi.org\/10.1002\/jbmr.4780","journal-title":"J Bone Miner Res"},{"key":"2760_CR151","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/jbmr.4016","volume":"35","author":"DB Karpf","year":"2020","unstructured":"Karpf DB, Pihl S, Mourya S et al (2020) A randomized double-blind placebo-controlled first-in-human phase 1 trial of TransCon PTH in healthy adults. J Bone Miner Res 35:1430\u20131440. https:\/\/doi.org\/10.1002\/jbmr.4016","journal-title":"J Bone Miner Res"},{"key":"2760_CR152","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1210\/clinem\/dgaf048","volume":"110","author":"BL Clarke","year":"2025","unstructured":"Clarke BL, Khan AA, Rubin MR et al (2025) Correction to: Efficacy and safety of transcon PTH in adults with hypoparathyroidism: 52-Week results from the phase 3 pathway trial. J Clin Endocrinol Metab 110:951\u2013960. https:\/\/doi.org\/10.1210\/clinem\/dgaf048","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR153","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","volume":"107","author":"AA Khan","year":"2022","unstructured":"Khan AA, Rejnmark L, Rubin M et al (2022) PaTH forward: a randomized, double-blind, placebo-controlled phase 2 trial of TransCon PTH in adult hypoparathyroidism. J Clin Endocrinol Metab 107:e372\u2013e385. https:\/\/doi.org\/10.1210\/clinem\/dgab577","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR154","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","volume":"38","author":"AA Khan","year":"2023","unstructured":"Khan AA, Rubin MR, Schwarz P et al (2023) Efficacy and safety of parathyroid hormone replacement with transcon PTH in hypoparathyroidism: 26-Week results from the phase 3 pathway trial. J Bone Miner Res 38:14\u201325. https:\/\/doi.org\/10.1002\/jbmr.4726","journal-title":"J Bone Miner Res"},{"key":"2760_CR155","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","volume":"41","author":"L Rejnmark","year":"2024","unstructured":"Rejnmark L, Gosmanova EO, Khan AA et al (2024) Palopegteriparatide treatment improves renal function in adults with chronic hypoparathyroidism: 1-year results from the phase 3 pathway trial. Adv Ther 41:2500\u20132518. https:\/\/doi.org\/10.1007\/s12325-024-02843-8","journal-title":"Adv Ther"},{"key":"2760_CR156","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.50.PL1","volume":"50","author":"A Arnold","year":"2017","unstructured":"Arnold A (2017) Primary hyperparathyroidism: molecular genetic insights and clinical implications. Endocrine Abstracts 50:PL1. https:\/\/doi.org\/10.1530\/endoabs.50.PL1","journal-title":"Endocrine Abstracts"},{"key":"2760_CR157","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/en.2015-1726","volume":"157","author":"G Hattersley","year":"2016","unstructured":"Hattersley G, Dean T, Corbin BA et al (2016) Binding selectivity of abaloparatide for PTH-Type-1-Receptor conformations and effects on downstream signaling. Endocrinology 157:141\u2013149. https:\/\/doi.org\/10.1210\/en.2015-1726","journal-title":"Endocrinology"},{"key":"2760_CR158","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jbmr.2769","volume":"31","author":"R Bi","year":"2016","unstructured":"Bi R, Fan Y, Lauter K et al (2016) Diphtheria toxin- and GFP-based mouse models of acquired hypoparathyroidism and treatment with a long-acting parathyroid hormone analog. J Bone Miner Res 31:975\u2013984. https:\/\/doi.org\/10.1002\/jbmr.2769","journal-title":"J Bone Miner Res"},{"key":"2760_CR159","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/jbmr.2811","volume":"31","author":"M Shimizu","year":"2016","unstructured":"Shimizu M, Joyashiki E, Noda H et al (2016) Pharmacodynamic actions of a long-acting PTH analog (LA-PTH) in thyroparathyroidectomized (TPTX) rats and normal monkeys. J Bone Miner Res 31:1405\u20131412. https:\/\/doi.org\/10.1002\/jbmr.2811","journal-title":"J Bone Miner Res"},{"key":"2760_CR160","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1210\/clinem\/dgae121","volume":"109","author":"I Takacs","year":"2024","unstructured":"Takacs I, Mezosi E, Soto A et al (2024) An open-label phase 2 study of eneboparatide, a novel PTH receptor 1 agonist, in hypoparathyroidism. J Clin Endocrinol Metab 109:2199\u20132209. https:\/\/doi.org\/10.1210\/clinem\/dgae121","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR161","unstructured":"Amolyt Pharma (2025) Evaluation of the safety and efficacy of eneboparatide (AZP-3601) in patients with Chronic Hypoparathyroidism (CALYPSO)"},{"key":"2760_CR162","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000868","author":"C Chiang","year":"2024","unstructured":"Chiang C (2024) Hypoparathyroidism update. Curr Opin Endocrinol Diabetes Obes. https:\/\/doi.org\/10.1097\/MED.0000000000000868","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2760_CR163","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s12020-024-03765-9","volume":"84","author":"F Cherchir","year":"2024","unstructured":"Cherchir F, Oueslati I, Yazidi M et al (2024) Long-term complications of permanent hypoparathyroidism in adults: prevalence and associated factors. Endocrine 84:1164\u20131171. https:\/\/doi.org\/10.1007\/s12020-024-03765-9","journal-title":"Endocrine"},{"key":"2760_CR164","doi-asserted-by":"publisher","first-page":"e3557","DOI":"10.1210\/clinem\/dgaa490","volume":"105","author":"KS Chen","year":"2020","unstructured":"Chen KS, Gosmanova EO, Curhan GC et al (2020) Five-year estimated glomerular filtration rate in patients with hypoparathyroidism treated with and without rhPTH(1\u201384). J Clin Endocrinol Metab 105:e3557\u2013e3565. https:\/\/doi.org\/10.1210\/clinem\/dgaa490","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02760-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02760-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02760-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:47:39Z","timestamp":1775479659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02760-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":164,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2760"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02760-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The first and Corresponding Author of this paper is an associate Editor of JENI. All other authors declare that they have no conflicts of interest regarding material presented in this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No approval needed for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}